Rights and permissions
About this article
Cite this article
Initiating rasagiline worth it in early Parkinson's disease. Pharmacoecon. Outcomes News 501, 5 (2006). https://doi.org/10.2165/00151234-200605010-00012
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200605010-00012